Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-059110
Filing Date
2023-05-11
Accepted
2023-05-11 16:05:45
Documents
5
Effectiveness Date
2023-05-11

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2314630d1_s8.htm S-8 73440
2 EXHIBIT 5.1 tm2314630d1_ex5-1.htm EX-5.1 6330
3 EXHIBIT 23.1 tm2314630d1_ex23-1.htm EX-23.1 1817
4 EX-FILING FEES tm2314630d1_ex-filingfees.htm EX-FILING FEES 25558
5 GRAPHIC tm2314630d1_ex5-1img01.jpg GRAPHIC 4727
  Complete submission text file 0001104659-23-059110.txt   114773
Mailing Address 1715 38TH ST BOULDER CO 80301
Business Address 1715 38TH ST BOULDER CO 80301 720-262-7002
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

IRS No.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-271836 | Film No.: 23910918
SIC: 2834 Pharmaceutical Preparations